Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni. / Madsen, Caroline; Prahm, Kira Philipsen; Nilsson, Cecilia; Pedersen, Lars Henning; Dziegiel, Morten Hanefeld; Hedegaard, Morten.

In: Ugeskrift for Laeger, Vol. 180, No. 17, V03170211, 2018, p. 2-6.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Madsen, C, Prahm, KP, Nilsson, C, Pedersen, LH, Dziegiel, MH & Hedegaard, M 2018, 'Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni', Ugeskrift for Laeger, vol. 180, no. 17, V03170211, pp. 2-6. <http://ugeskriftet.dk/videnskab/opsaetning-af-screeningsprogram-i-danmark-foetal-og-neonatal-alloimmun-trombocytopeni>

APA

Madsen, C., Prahm, K. P., Nilsson, C., Pedersen, L. H., Dziegiel, M. H., & Hedegaard, M. (2018). Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni. Ugeskrift for Laeger, 180(17), 2-6. [V03170211]. http://ugeskriftet.dk/videnskab/opsaetning-af-screeningsprogram-i-danmark-foetal-og-neonatal-alloimmun-trombocytopeni

Vancouver

Madsen C, Prahm KP, Nilsson C, Pedersen LH, Dziegiel MH, Hedegaard M. Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni. Ugeskrift for Laeger. 2018;180(17):2-6. V03170211.

Author

Madsen, Caroline ; Prahm, Kira Philipsen ; Nilsson, Cecilia ; Pedersen, Lars Henning ; Dziegiel, Morten Hanefeld ; Hedegaard, Morten. / Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni. In: Ugeskrift for Laeger. 2018 ; Vol. 180, No. 17. pp. 2-6.

Bibtex

@article{86f72c14ef2c4a86ad1ddb46bfb29df6,
title = "Ops{\ae}tning af screeningsprogram i Danmark for f{\o}tal og neonatal alloimmun trombocytopeni",
abstract = "Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia (FNAIT) can cause cerebral haemorrhage in newborns. FNAIT occurs in women, who do not have the thrombocyte type human platelet antigen (HPA)-1a and are carrying an HPA-1a positive foetus. Maternal antibodies can cause thrombocytopenia in the foetus or newborn. Antenatal screening for FNAIT can easily be integrated in the already existing national screening programme for rhesus immunisation. Prophylactic treatment with immunoglobulines for pregnancies at risk can prevent neonatal complications. We argue, that the WHO criteria for a screening programme for FNAIT are met.",
author = "Caroline Madsen and Prahm, {Kira Philipsen} and Cecilia Nilsson and Pedersen, {Lars Henning} and Dziegiel, {Morten Hanefeld} and Morten Hedegaard",
year = "2018",
language = "Dansk",
volume = "180",
pages = "2--6",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "17",

}

RIS

TY - JOUR

T1 - Opsætning af screeningsprogram i Danmark for føtal og neonatal alloimmun trombocytopeni

AU - Madsen, Caroline

AU - Prahm, Kira Philipsen

AU - Nilsson, Cecilia

AU - Pedersen, Lars Henning

AU - Dziegiel, Morten Hanefeld

AU - Hedegaard, Morten

PY - 2018

Y1 - 2018

N2 - Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia (FNAIT) can cause cerebral haemorrhage in newborns. FNAIT occurs in women, who do not have the thrombocyte type human platelet antigen (HPA)-1a and are carrying an HPA-1a positive foetus. Maternal antibodies can cause thrombocytopenia in the foetus or newborn. Antenatal screening for FNAIT can easily be integrated in the already existing national screening programme for rhesus immunisation. Prophylactic treatment with immunoglobulines for pregnancies at risk can prevent neonatal complications. We argue, that the WHO criteria for a screening programme for FNAIT are met.

AB - Establishing a screening programme in Denmark for foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia (FNAIT) can cause cerebral haemorrhage in newborns. FNAIT occurs in women, who do not have the thrombocyte type human platelet antigen (HPA)-1a and are carrying an HPA-1a positive foetus. Maternal antibodies can cause thrombocytopenia in the foetus or newborn. Antenatal screening for FNAIT can easily be integrated in the already existing national screening programme for rhesus immunisation. Prophylactic treatment with immunoglobulines for pregnancies at risk can prevent neonatal complications. We argue, that the WHO criteria for a screening programme for FNAIT are met.

M3 - Tidsskriftartikel

C2 - 29717700

VL - 180

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 17

M1 - V03170211

ER -

ID: 199347488